| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | May 31, 2022 | Rosenblum Mark J EVP Finance CFO | Buy | Salarius Pharmaceuticals, Inc. | SLRX | $0.18 | $5,040 | +15.88% |
| Mar 03, 2022 | Mar 09, 2022 | Rosenblum Mark J EVP Finance CFO | Buy | Salarius Pharmaceuticals, Inc. | SLRX | $0.39 | $29,812 | +40.87% |
| Aug 17, 2020 | Aug 18, 2020 | Rosenblum Mark J EVP Finance CFO | Buy | Salarius Pharmaceuticals, Inc. | SLRX | $1 | $5,000 | +29.41% |
| Feb 19, 2020 | Feb 20, 2020 | Rosenblum Mark J EVP Finance CFO | Buy | Salarius Pharmaceuticals, Inc. | SLRX | $0.95 | $1,900 | +22.22% |
| Feb 13, 2020 | Feb 13, 2020 | Rosenblum Mark J EVP Finance CFO | Buy | Salarius Pharmaceuticals, Inc. | SLRX | $0.86 | $4,295 | +50.00% |
| Oct 24, 2013 | Oct 29, 2013 | Rosenblum Mark J CFO | Buy | Advaxis, Inc. | ADXS | $4 | $48,000 | +34.38% |